| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |